The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates. The ...

Influenza Pipeline Summary. DelveInsight’s Influenza Emerging Drugs report highlights innovative therapies advancing the ...

With three new antibiotics set to shake up the stagnant treatment landscape for uncomplicated urinary tract infections (uUTIs ...

In a study published in Nature, a global team of researchers developed a new technology called pathology-oriented multiplexing, or PathoPlex, to map more than 140 different proteins across 40 tissue ...

In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...

The thyroid gland disorder treatments market is witnessing substantial growth, fueled by the increasing incidence of conditions like hypothyroidism and hyperthyroidism. Greater awareness about the ...

The pharmaceutical drug delivery market is entering a transformative phase, projected to grow from USD 1,949.4 billion in ...

China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on ...

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration ...

Each organ in the human body contains different types of cells arranged in specific ways.These arrangements aid protein interactions, which drive ...

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that “Americans must therefore have access to the most-favored-nation price.” ...